HLX 0205
Alternative Names: HLX-0205Latest Information Update: 14 Sep 2022
At a glance
- Originator Healx
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Fragile X syndrome